TrialThe journal of prevention of Alzheimer's disease2024

Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 Study.

K V Papp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.